HealthCare Global Enterprises (HCG.BO) Earnings Analysis
HealthCare Global Enterprises (HCG.BO) next reports earnings on 2026-08-06, consensus EPS 2.79 INR. Last quarter (2026-05-19) it missed with EPS 0.15 INR vs 1.5 INR est (-90%). It has beaten estimates in 2/8 recent quarters (25%). Trailing P/E 685.51.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does HCG.BO next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 2.79 INR |
| Revenue estimate | 7.03B |
HCG.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-19 | 0.15 INR | 1.5 INR | -90% | Miss |
| 2026-02-05 | 0.09939 INR | 0.735 INR | -86.5% | Miss |
| 2025-09-30 | 1.16 INR | 1.47 INR | -21.1% | Miss |
| 2025-08-11 | 0.34 INR | 0.696 INR | -51.1% | Miss |
| 2025-05-27 | 0.52 INR | 0.596 INR | -12.8% | Miss |
| 2025-02-14 | 0.596 INR | 0.55 INR | +8.4% | Beat |
| 2024-11-09 | 1.28 INR | 1.17 INR | +9.4% | Beat |
| 2024-08-08 | 0.86 INR | 1.35 INR | -36.3% | Miss |
Beat rate: 2/8 (25%) over reported quarters with consensus data.
HCG.BO valuation and analyst view
| Trailing P/E | 685.51 |
|---|---|
| Trailing EPS | 0.95115 INR |
| Price / book | 7.30 |
| Dividend yield | 0.00% |
| Market cap | 100.14B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is HealthCare Global Enterprises (HCG.BO)'s next earnings date?
HealthCare Global Enterprises is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 2.79 INR and revenue estimate of 7.03B.
Did HCG.BO beat earnings last quarter?
In its 2026-05-19 report, HCG.BO posted EPS of 0.15 INR versus a 1.5 INR estimate — a miss of 90%.
What is HCG.BO's earnings track record?
Over the last 8 reported quarters with consensus data, HCG.BO beat estimates 2 times (25%).
What is HCG.BO's current P/E ratio and EPS?
HCG.BO trades at a trailing P/E of 685.51 on trailing EPS of 0.9511520715411242 INR.
What do analysts rate HCG.BO?
HCG.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.